Advertisement

Topics

Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

07:34 EDT 1 Aug 2018 | BioPortfolio Reports

Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Celldex Therapeutics Celldex or 'the company' is a biopharmaceutical company engaged in the development of immunotherapy technologies for cancer and other diseases. The company operates in the US. It is headquartered in Hampton, New Jersey, and employed 199 people of which 196 were fulltime employees 1 part time and 2 interns as on December 31, 2015.


Scope


Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis

An indepth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments

Intelligence on Celldex Therapeutics, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Celldex Therapeutics, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Celldex Therapeutics, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Celldex Therapeutics, Inc.'s business structure, strategy and prospects.

Original Article: Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Celldex Therapeutics, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...